Monitoring the treatment of paget's disease with etidronate
- 1 December 1984
- journal article
- Published by Springer Nature in Calcified Tissue International
- Vol. 36 (1) , 629-631
- https://doi.org/10.1007/bf02405380
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASEThe Lancet, 1984
- Review of Fracture Experience During Treatment of Paget??s Disease of Bone with Etidronate Disodium (EHDP)Published by Wolters Kluwer Health ,1983
- DIPHOSPHONATES AND INHIBITION OF BONE MINERALISATIONThe Lancet, 1982
- Calcitonin and diphosphonate in the treatment of paws disease of boneMetabolic Bone Disease and Related Research, 1981
- Paget's bloom of bone : Diagnosis and managementMetabolic Bone Disease and Related Research, 1981
- Effects of ethane-1 hydroxy-1, 1-Diphosphonate (5 mg/kg/day dose) onquantitative bone histology in paget's disease of boneMetabolic Bone Disease and Related Research, 1981
- Clinical and biochemical effects of EHDP in Paget's disease of bone: Patterns of response to initial treatment and to long-term therapyMetabolic Bone Disease and Related Research, 1981
- Use of etidronate (ehdp) in paget's disease of boneArthritis & Rheumatism, 1980
- The Treatment of Pagetʼs Bone Disease with Sodium EthidronateThe Lancet Healthy Longevity, 1979
- Influence of Disodium Etidronate on Clinical and Laboratory Manifestations of Paget's Disease of Bone (Osteitis Deformans)New England Journal of Medicine, 1973